Results

Total Results: 74 records

Showing results for "venous".

  1. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - raloxifene increase the risk for thromboembolic events (for example, stroke, pulmonary embolism, and deep venous … younger; have no predisposition to thromboembolic events such as stroke, pulmonary embolism, or deep venous … incidence between the tamoxifen and placebo groups in this age group. 7 The relative risk increase in venous … thromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism … n § 1 3 9 20 Pulmonary emboli caused, n § 1-2 4-5 9 18 Cases of deep venous
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
    July 02, 2002 - raloxifene increase the risk for thromboembolic events (for example, stroke, pulmonary embolism, and deep venous … younger; have no predisposition to thromboembolic events such as stroke, pulmonary embolism, or deep venous … incidence between the tamoxifen and placebo groups in this age group.7 The relative risk increase in venous … thromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism … 1-2 12 21 22 Strokes caused, n§ 1 3 9 20 Pulmonary emboli caused, n§ 1-2 4-5 9 18 Cases of deep venous
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/nV4GCeHGsZrfKUWxo9_zZb
    April 01, 2023 - • The IGRA requires a single venous blood sample that measures the CD4 T-cell response to specific
  4. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
    September 02, 2021 - infarction Renal or hepatic injury/failure Pulmonary edema, adult respiratory distress syndrome Venous
  5. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide_3.pdf
    September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venous
  6. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
    September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venous
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med . 2012;367:1979-87. … CVD = cardiovascular disease; DAMAD = Dipyridamole Aspirin Microangiopathy of Diabetes; DVT = deep venous … Atherosclerosis; AMIS = Aspirin Myocardial Infarction Study; ASPIRE = Aspirin to Prevent Recurrent Venous … for Asymptomatic Atherosclerosis; ABI = ankle–brachial index; ASPIRE = Aspirin to Prevent Recurrent Venous … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
    April 17, 2018 - incident kidney stones, incident cancer, and incident cardiovascular disease (including stroke and venous … 0.47%]; HR, 0.90 [95% CI, 0.54 to 1.50]). 17 Similar, nonsignificant findings were found for stroke, venous … 0.11% [95% CI, −0.20% to 0.41%]; HR, 1.03 [95% CI, 0.90 to 1.19]). 29 Similar findings for stroke, venous … were also reported (stroke: ARD, −0.09% [95% CI, −0.38% to 0.20%] and HR, 0.95 [95% CI, 0.82 to 1.10]; venous … The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism: from the
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
    May 02, 2023 - The IGRA requires a single venous blood sample that measures the CD4 T-cell response to specific Mycobacterium … protein derivative and interpret the response 48 to 72 hours later. 25 , 27 The IGRA requires a single venous … Screening with an IGRA requires obtaining a single venous blood sample, and patients do not need to return … However, clinicians should be aware of processing requirements for blood samples and ensure that venous
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
    August 01, 2022 - ° The IGRA requires a single venous blood sample that measures the CD4 T-cell response to specific … protein derivative and interpret the response 48 to 72 hours later.25,27 The IGRA requires a single venous … Screening with an IGRA requires obtaining a single venous blood sample, and patients do not need to return … However, clinicians should be aware of processing require- ments for blood samples and ensure that venous
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Yc24U4wMLXGoqE5NjwRVA6
    April 17, 2018 - i d e n t c a n c e r, a n d i n c i d e n t c a r d i o va s - cular disease (including stroke and venous … 0.47%]; HR, 0.90 [95% CI, 0.54 to 1.50]).17 Similar, nonsignificant findings were found for stroke, venous … , 0.11% [95% CI, −0.20% to 0.41%]; HR, 1.03 [95% CI, 0.90 to 1.19]).29 Similar findings for stroke, venous … 95% CI, 0.90 to 1.19) Stroke: ARD, −0.09% (95% CI, −0.38% to 0.20%); HR, 0.95 (95% CI, 0.82 to 1.10) Venous … The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism: from the
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
    April 01, 2016 - CVD = cardiovascular disease; DAMAD = Dipyridamole Aspirin Microangiopathy of Diabetes; DVT = deep venous … Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367:1979- 87. … Atherosclerosis; AMIS = Aspirin Myocardial Infarction Study; ASPIRE = Aspirin to Prevent Recurrent Venous … for Asymptomatic Atherosclerosis; ABI = ankle–brachial index; ASPIRE = Aspirin to Prevent Recurrent Venous … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/BwAo_shwmJLSRguyWxaXpP
    July 01, 2007 - treatment in children. 3 Accuracy of Screening Tests TC and HDL-C can be measured on nonfasting venous … samples, LDL-C measurement requires fasting samples, and direct LDL-C can be measured on nonfasting venous
  14. www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening-september-2016
    September 06, 2016 - Interferon-gamma release assays require a single venous blood sample and laboratory processing within … the test results within the proper time frame. 26 Screening with an IGRA requires obtaining a single venous … However, clinicians should be aware of processing requirements for blood samples and ensure that venous
  15. www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening-2007
    July 15, 2007 - Accuracy of Screening Tests TC and HDL-C can be measured on nonfasting venous or capillary blood samples … , LDL-C requires fasting samples, and direct LDL-C can be measured on nonfasting venous samples.
  16. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - first 3 years of tamoxifen use. 111 Age older than 60 years was also an important risk factor for venous … 95% CI, 1.03-1.80]) and stroke (odds ratio, 3.36 [95% CI, 1.04-14.18]) with anastrozole and increased venous … also indicated associations with increased fractures for aromatase inhibitors but no differences for venous … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. … with tamoxifen 0.97 (0.86-1.12) 2 NA NA 1.05 (0.87-1.28) 2 NA NA Harms Venous
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wx_w92ukxeDvNShoRQXbhP
    September 06, 2016 - Interferon-gamma release assays require a single venous blood sample and laboratory processing within … the test results within the proper time frame.26 Screening with an IGRA requires obtaining a single venous … However, clinicians should be aware of processing requirements for blood samples and ensure that venous
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
    September 03, 2019 - PE, pulmonary embolism; RR, risk ratio; RUTH, Raloxifene Use for the Heart; SE, standard error; VTE, venous … the first 3 years of tamoxifen use.111 Age older than 60 years was also an important risk factor for venous … CI, 1.03- 1.80]) and stroke (odds ratio, 3.36 [95% CI, 1.04-14.18]) with anastrozole and increased venous … also indicated associations with increased fractures for aromatase inhibitors but no differences for venous … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
  19. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
    September 15, 2013 - Risk Reduction The USPSTF found adequate evidence that tamoxifen and raloxifene increase risk for venous … tamoxifen nor raloxifene should be used in women who have a history of thromboembolic events (deep venous … Women with a personal or family history of venous thromboembolism are at higher risk for these adverse … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - Risk Reduction The USPSTF found adequate evidence that tamoxifen and raloxifene increase risk for venous … tamoxifen nor raloxifene should be used in women who have a history of thrombo- embolic events (deep venous … Women with a personal or family history of venous thromboembolism are at higher risk for these ad- verse … Effect of tamoxifen on venous thrombo- embolic events in a breast cancer prevention trial.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: